The effects of protein corona on in vivo fate of nanocarriers

Adv Drug Deliv Rev. 2022 Jul:186:114356. doi: 10.1016/j.addr.2022.114356. Epub 2022 May 17.

Abstract

With the emerging advances in utilizing nanocarriers for biomedical applications, a molecular-level understanding of the in vivo fate of nanocarriers is necessary. After administration into human fluids, nanocarriers can attract proteins onto their surfaces, forming an assembled adsorption layer called protein corona (PC). The formed PC can influence the physicochemical properties and subsequently determine nanocarriers' biological behaviors. Therefore, an in-depth understanding of the features and effects of the PC on the nanocarriers' surface is the first and most important step towards controlling their in vivo fate. This review introduces fundamental knowledge such as the definition, formation, composition, conformation, and characterization of the PC, emphasizing the in vivo environmental factors that control the PC formation. The effect of PC on the physicochemical properties and thus biological behaviors of nanocarriers was then presented and thoroughly discussed. Finally, we proposed the design strategies available for engineering PC onto nanocarriers to manipulate them with the desired surface properties and achieve the best biomedical outcomes.

Keywords: Drug delivery; In vivo fate; Nanoparticles; Protein corona; Protein-nanomaterial interaction.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Nanoparticles* / chemistry
  • Protein Corona* / chemistry
  • Proteins / chemistry
  • Surface Properties

Substances

  • Protein Corona
  • Proteins